TNF and cancer: To study this, we used the available time‐course data of four different cancer cell lines (A549, lung; DU145, prostate; OVCA420, ovarian; MCF‐7, breast) treated with TNF‐α (positive regulator of IP) and TGF‐β1 (negative regulator of IP) [29].